Cardiovascular Imaging with PET, CT, and MR Imaging

Amol Takalkar; Wengen Chen; Benoit Desjardins; Abass Alavi; Drew A Torigian

doi:10.1016/j.cpet.2009.03.004

Cardiovascular Imaging with PET, CT, and MR Imaging

PET Clin. 2008 Jul;3(3):411-34. doi: 10.1016/j.cpet.2009.03.004. Epub 2009 Jun 21.

Authors

Amol Takalkar¹, Wengen Chen², Benoit Desjardins², Abass Alavi², Drew A Torigian²

Affiliations

¹ PET Imaging Center, Biomedical Research Foundation of Northwest Louisiana, 1505 Kings Highway, Shreveport, LA 71103, USA; Department of Radiology, LSUHSC-S, 1501 Kings Highway, Shreveport, LA 71103, USA. Electronic address: amoltakalkar@yahoo.com.
² Department of Radiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.

PMID: 27156669
DOI: 10.1016/j.cpet.2009.03.004

Abstract

PET provides high-resolution images of radiopharmaceutical biodistribution in vivo. Fluorine-18-labeled fluorodeoxyglucose (FDG)-PET is an established entity in the work-up of several oncologic disorders and is making forays in the diagnosis of inflammatory diseases, leading to increased use for cardiac and neurologic applications. Combined myocardial perfusion and metabolism imaging using FDG-PET is the gold standard for noninvasive assessment of myocardial viability. Advances in imaging instrumentation (including CT and MR imaging technology) facilitate noninvasive assessment of cardiovascular pathologies. MR imaging is best placed to provide the most comprehensive cardiac evaluation. This article addresses evaluation of the cardiovascular system by PET, CT, and MR imaging.

Keywords: Cardiac CT; Cardiac MR; Cardiac PET; FDG; Myocardial viability.

Publication types

Review